VER-01 for neuralgia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Jun 2024: Trial registered, NCT06475001
  2. 28 Jun 2024: Trial started, NCT06475001

The trials

NCT06475001: Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

State
Completed
Phase
Phase 2
People
652 taking part
Started
28 Jun 2024
Primary completion
31 Jul 2025
Arms
VER-01
Results
None posted
  1. 26 Jun 2024: Trial registered
  2. 28 Jun 2024: Trial started
  3. 31 Jul 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.